Seelos Therapeutics Inc (SEEL)
0.615
-0.03
(-5.09%)
USD |
NASDAQ |
Jun 26, 13:18
Seelos Therapeutics Accounts Receivable (Quarterly): 0.968M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.968M |
December 31, 2023 | 0.763M |
September 30, 2023 | 0.221M |
June 30, 2023 | 0.431M |
March 31, 2023 | 0.793M |
December 31, 2022 | 0.00 |
September 30, 2022 | |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | |
September 30, 2021 | |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 |
Date | Value |
---|---|
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | 0.398M |
June 30, 2016 | 0.687M |
March 31, 2016 | 0.688M |
December 31, 2015 | 0.519M |
September 30, 2015 | 0.575M |
June 30, 2015 | 0.664M |
March 31, 2015 | 0.513M |
December 31, 2014 | 0.678M |
September 30, 2014 | 0.829M |
June 30, 2014 | 0.049M |
March 31, 2014 | 0.069M |
December 31, 2013 | 0.059M |
September 30, 2013 | 0.035M |
June 30, 2013 | 0.681M |
March 31, 2013 | 0.499M |
December 31, 2012 | 0.652M |
September 30, 2012 | 3.807M |
June 30, 2012 | 0.4606M |
March 31, 2012 | 0.8919M |
December 31, 2011 | 0.021M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2022
0.968M
Maximum
Mar 2024
0.5293M
Average
0.597M
Median
Accounts Receivable (Quarterly) Benchmarks
180 Life Sciences Corp | -- |
Johnson & Johnson | 14.95B |
NovaBay Pharmaceuticals Inc | 0.734M |
Palatin Technologies Inc | 0.00 |
iBio Inc | -- |